131 related articles for article (PubMed ID: 37183140)
1. Endometrioid adenocarcinoma: combined multiparametric MRI and tumour marker HE4 to evaluate tumour grade and lymphovascular space invasion.
Yue XN; He XY; Wu JJ; Fan W; Zhang HJ; Wang CW
Clin Radiol; 2023 Aug; 78(8):e574-e581. PubMed ID: 37183140
[TBL] [Abstract][Full Text] [Related]
2. Preoperative prediction of lymphovascular space invasion in endometrioid adenocarcinoma: an MRI-based radiomics nomogram with consideration of the peritumoral region.
Yan B; Jia Y; Li Z; Ding C; Lu J; Liu J; Zhang Y
Acta Radiol; 2023 Sep; 64(9):2636-2645. PubMed ID: 37312525
[TBL] [Abstract][Full Text] [Related]
3. Semi-quantitative and quantitative dynamic contrast-enhanced (DCE) MRI parameters as prostate cancer imaging biomarkers for biologically targeted radiation therapy.
Reynolds HM; Tadimalla S; Wang YF; Montazerolghaem M; Sun Y; Williams S; Mitchell C; Finnegan ME; Murphy DG; Haworth A
Cancer Imaging; 2022 Dec; 22(1):71. PubMed ID: 36536464
[TBL] [Abstract][Full Text] [Related]
4. Volumetric ADC histogram analysis for preoperative evaluation of LVSI status in stage I endometrioid adenocarcinoma.
Ma X; Ren X; Shen M; Ma F; Chen X; Zhang G; Qiang J
Eur Radiol; 2022 Jan; 32(1):460-469. PubMed ID: 34137929
[TBL] [Abstract][Full Text] [Related]
5. Prediction of tumor grade and lymphovascular space invasion in endometrial adenocarcinoma with MR imaging-based radiomic analysis.
Bereby-Kahane M; Dautry R; Matzner-Lober E; Cornelis F; Sebbag-Sfez D; Place V; Mezzadri M; Soyer P; Dohan A
Diagn Interv Imaging; 2020 Jun; 101(6):401-411. PubMed ID: 32037289
[TBL] [Abstract][Full Text] [Related]
6. Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma.
Chen X; Guo Q; Chen X; Zheng W; Kang Y; Cao D
BMC Med Imaging; 2024 Feb; 24(1):48. PubMed ID: 38373912
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MRI at 3T in Endometrial Cancer: Correlation of Apparent Diffusion Coefficient with Histopathological Prognostic Parameters.
Ozturk M; Kalkan C; Danaci M; Kefeli M
J Coll Physicians Surg Pak; 2021 Dec; 31(12):1399-1405. PubMed ID: 34794277
[TBL] [Abstract][Full Text] [Related]
8. Radiomics Analysis of Multiparametric MRI Evaluates the Pathological Features of Cervical Squamous Cell Carcinoma.
Wu Q; Shi D; Dou S; Shi L; Liu M; Dong L; Chang X; Wang M
J Magn Reson Imaging; 2019 Apr; 49(4):1141-1148. PubMed ID: 30230114
[TBL] [Abstract][Full Text] [Related]
9. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymphovascular Space Invasion in Endometrial Carcinoma.
Luo Y; Mei D; Gong J; Zuo M; Guo X
J Magn Reson Imaging; 2020 Oct; 52(4):1257-1262. PubMed ID: 32315482
[TBL] [Abstract][Full Text] [Related]
11. The feasibility of a radial turbo-spin-echo T2 mapping for preoperative prediction of the histological grade and lymphovascular space invasion of cervical squamous cell carcinoma.
Li S; Zhang Z; Liu J; Zhang F; Yang M; Lu H; Zhang Y; Han F; Cheng J; Zhu J
Eur J Radiol; 2021 Jun; 139():109684. PubMed ID: 33836336
[TBL] [Abstract][Full Text] [Related]
12. The invasion status of lymphovascular space and lymph nodes in cervical cancer assessed by mono-exponential and bi-exponential DWI-related parameters.
Mi HL; Suo ST; Cheng JJ; Yin X; Zhu L; Dong SJ; Huang SS; Lin C; Xu JR; Lu Q
Clin Radiol; 2020 Oct; 75(10):763-771. PubMed ID: 32723502
[TBL] [Abstract][Full Text] [Related]
13. Biparametric Magnetic Resonance Imaging as an Adjunct to CA125 and HE4 to Improve Characterization of Large Ovarian Masses.
Manganaro L; Anastasi E; Porpora MG; Vinci V; Saldari M; Bernardo S; Ballesio L; Sollazzo P; Pecorella I; Recchia N; Stracci F; Panici PB; Angeloni A; Catalano C; Scialpi M
Anticancer Res; 2015 Nov; 35(11):6341-51. PubMed ID: 26504074
[TBL] [Abstract][Full Text] [Related]
14. Roles of DWI and T2-weighted MRI volumetry in the evaluation of lymph node metastasis and lymphovascular invasion of stage IB-IIA cervical cancer.
Wang Y; Chen X; Pu H; Yuan Y; Li S; Chen G; Liu Y; Li H
Clin Radiol; 2022 Mar; 77(3):224-230. PubMed ID: 35000761
[TBL] [Abstract][Full Text] [Related]
15. [The value of T2 mapping for evaluating the pathological type, grade and depth of myometrial invasion in endometrial carcinoma].
Li SJ; Zhang ZX; Liu J; Wang WJ; Wang J; Zhang Y; Cheng JL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):673-680. PubMed ID: 37580272
[No Abstract] [Full Text] [Related]
16. Preliminary MRI Study of Extracellular Volume Fraction for Identification of Lymphovascular Space Invasion of Cervical Cancer.
Wang W; Fan X; Yang J; Wang X; Gu Y; Chen M; Jiang Y; Liu L; Zhang M
J Magn Reson Imaging; 2023 Feb; 57(2):587-597. PubMed ID: 36094153
[TBL] [Abstract][Full Text] [Related]
17. Glioma grading prediction using multiparametric magnetic resonance imaging-based radiomics combined with proton magnetic resonance spectroscopy and diffusion tensor imaging.
Lin K; Cidan W; Qi Y; Wang X
Med Phys; 2022 Jul; 49(7):4419-4429. PubMed ID: 35366379
[TBL] [Abstract][Full Text] [Related]
18. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
19. Preoperative markers for the prediction of high-risk features in endometrial cancer.
Panyavaranant P; Manchana T
World J Clin Oncol; 2020 Jun; 11(6):378-388. PubMed ID: 32874951
[TBL] [Abstract][Full Text] [Related]
20. Whole-tumor histogram analysis of apparent diffusion coefficients for predicting lymphovascular space invasion in stage IB-IIA cervical cancer.
Cheng JM; Luo WX; Tan BG; Pan J; Zhou HY; Chen TW
Front Oncol; 2023; 13():1206659. PubMed ID: 37404753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
